Navigation Links
CYT003 in Medical News

Anti-allergy vaccine based on 'hygiene hypothesis'

...d by a Swiss-based Cytos Biotechnology company to develop an anti-allergy drug that makes the immune system to focus on mycobacteria. This drug called cyt003 – QbG10 activates the immune system to attack potentially larger threats like mycobacteria, a group of bacteria found in soil and water that are come ...
CYT003 in other areas

PipelineReview.com - Biotech News & Online Store - Cytos Biotechnology ...

... Industry, Cytos Biotechnology starts phase IIb clinical study with CYT003-QbG10 ... CYT003- QbG10 has previously been demonstrated to be safe, very ...

CYT003-QbG10 Monotherapy For The Treatment Of Allergic Diseases Is Safe ...

Cytos Biotechnology Ltd (SWX:CYTN) announced results from two randomized, double-blind, placebo-controlled, multicentre phase II studies with CYT003-QbG10 ...

Start Of Phase IIb Clinical Study With CYT003-QbG10 Monotherapy For The ...

Cytos Biotechnology Ltd (SIX:CYTN) announced today that it has started a phase IIb clinical study with CYT003-QbG10, an allergen-independent immunotherapeutic ...

Cytos Biotechnology - Preventing Chronic Diseases – a Vital Investment

Conference Call / Webcast about CYT003-QbG10 phase IIb results. Archived ... CYT003-QbG10 monotherapy for the treatment of allergic rhinoconjunctivitis is ...

Universal allergy treatment going to Phase III clinical trials

Cytos Biotechnology has a product CYT003-QbG10 with the potential to treat many ... Study 08 with CYT003-QbG10 monotherapy included 80 patients suffering from house ...

A Study to Investigate an Immunomodulatory Therapy in Adult Patients ...

... extract in combination with CYT003-QbG10-placebo. Phase II ... Drug: CYT005-AllQbG10 (combination of house dust mite allergen extract with CYT003-QbG10) ...
Other Tags
(Date:3/3/2015)... The Data 360 Conference on “Healthcare’s Big ... Dearborn, MI, on March 5, 2015. Norman T. Kutemperor, ... He is known internationally as “The Father of NoSQL” and ... earned due to years of R&D on NoSQL DBs, culminating ... 10 years ago. Subsequent developments in Big Data-related technologies (such ...
(Date:3/3/2015)... The authors Tracey Webb and Richard Mowbray have always ... a good and healthy diet . In “ Crude ... created an ingenious book that shows readers how to prepare ... , “Crude Food” shows readers that, in modern society, people ... over processed refined foods , such as wheat, sugars ...
(Date:3/3/2015)... Dr. Stephen Edgerton, a ... has achieved Accredited Member Status in the American ... this accomplishment after completing a rigorous credentialing process ... the submission of clinical cases for examination. ... up in Connecticut, Charlotte, North Carolina, Caracas, Venezuela ...
(Date:3/3/2015)... 03, 2015 Aureus Medical Group (web: ... jobs, has announced that it will participate as an ... Tuesday, March 17, 2015 in St. Louis, MO. , ... meet job-seeking residents and fellows in a comfortable, relaxed ... will be available to speak with attendees about ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Formetco today ... billboard design. The FTX uses state-of-the-art technology to ... performance reliability, and owner satisfaction. An item of ... the exclusive Formetco 10 year LED Brightness Warranty. , ... to be a superior billboard among any other billboard ...
Breaking Medicine News(10 mins):Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 2Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 3Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:Formetco Launches Innovative LED Billboard System 2
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... Calif. , Jan. 27, 2015 /PRNewswire/ ... provider of globally deployed, innovative test solutions ... announced the delivery of its TS-323 ... Space Systems Company (LMSSC). GENASYS is a ... demands of mission-critical applications that require performance ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
Other Contents